https://clinicaltrials.gov/ct2/show/NCT03502616?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=09%2F06%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
DESCRIPTION:
Condition: Ankylosing Spondylitis
Intervention: Drug: Tofacitinib
Sponsor: Pfizer
Active, not recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03502616
FIRST POSTED:
Wed, 18 Apr 2018 12:00:00 EDT
LAST UPDATE POSTED:
09/20/19 07:01AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03502616?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=09%2F06%2F2019&lupd_d=14&sort=nwst